Showing results (1-10 of 874) with videos related to

Sort By:
Pageof 88
Clinical Kidney Journal|September 9, 2020
Often forgotten, transport modality to dialysis may be life-savingRaul Fernandez-Prado, Emilio Gonzalez-Parra, Alberto Ortiz
Clinical Kidney Journal|February 10, 2018
Women and renal replacement therapy in Europe: lower incidence, equal access to transplantation, longer survival than menRaul Fernandez-Prado, Beatriz Fernandez-Fernandez, Alberto Ortiz
Clinical Kidney Journal|October 30, 2020
Pelacarsen for lowering lipoprotein(a): implications for patients with chronic kidney diseaseRaul Fernandez-Prado, Maria Vanessa Perez-Gomez, Alberto Ortiz
Clinical Kidney Journal|February 10, 2021
Slo-Mo anti-neutrophil cytoplasmic antibody-associated renal vasculitisAlejandro Avello, Raul Fernandez-Prado, Begoña Santos-Sanchez-Rey, et al.
Clinical Kidney Journal|August 7, 2019
MYH9-related disease: it does exist, may be more frequent than you think and requires specific therapyRaul Fernandez-Prado, Sol Maria Carriazo-Julio, Roser Torra, et al.
The American Journal of Medicine|September 11, 2016
Creatinine Clearance Is Not Equal to Glomerular Filtration Rate and Cockcroft-Gault Equation Is Not Equal to CKD-EPI Collaboration EquationRaul Fernandez-Prado, Esmeralda Castillo-Rodriguez, Fernando Javier Velez-Arribas, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 10, 2024
Cefadroxil Targeting of SLC15A2/PEPT2 Protects From Colistin NephrotoxicityRaul Fernandez-Prado, Lara Valiño, Aranzazu Pintor-Chocano, et al.
The American Journal of Medicine|January 7, 2019
Potential Dangers of Serum Urate-Lowering TherapyMaria Vanessa Perez-Gomez, Lorenz-Alexander Bartsch, Esmeralda Castillo-Rodriguez, et al.
Diagnostic Pathology|May 17, 2019
Positive/retained SDHB immunostaining in renal cell carcinomas associated to germline SDHB-deficiency: case reportMarina Ugarte-Camara, Raul Fernandez-Prado, Isabel Lorda, et al.
Clinical Kidney Journal|January 4, 2021
The dirty little secret of urate-lowering therapy: useless to stop chronic kidney disease progression and may increase mortalityGuillermo Gonzalez-Martin, Jaime Cano, Sol Carriazo, et al.
Pageof 88